v3.26.1
Condensed Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
CURRENT ASSETS    
Cash and cash equivalents $ 2,976,535 $ 2,104,004
Investments at fair value 2,160,954
Accounts receivable, net of allowance 9,800 4,975
Inventory 29,378
Prepaid expenses 462,859 189,878
Other current assets 12,325 12,325
Total current assets 5,651,851 2,311,182
OTHER ASSETS    
Property and equipment, net 817,337 514,684
Right of use assets - operating leases 1,926,885 2,117,284
Patents, net of accumulated amortization of $3,636 and $2,603 271,064 272,097
Deferred offering costs 3,475,514 5,650,185
Other assets 301,257 65,633
Total other assets 6,792,057 8,619,883
TOTAL ASSETS 12,443,908 10,931,065
CURRENT LIABILITIES    
Accounts payable 249,611 183,993
Accrued expenses 1,669,322 538,234
Operating lease liability 424,215 392,950
Derivative liabilities 348,830 1,460,000
Convertible note payable, net of discount and debt issuance costs of $1,842,184, and $3,620,343, respectively 3,460,834 4,144,657
Note payable 15,088 9,140
Total current liabilities 6,167,900 6,728,974
LONG TERM LIABILITIES    
Operating lease liability 1,504,887 1,725,073
Note payables, net of current portion 31,563 1,418
Total long term liabilities 1,536,450 1,726,491
Total liabilities 7,704,350 8,455,465
Commitments and Contingencies (See Note 16)
STOCKHOLDERS’ EQUITY    
Common stock, $0.0002 par value, 200,000,000 authorized, 51,859,347 and 34,213,387 issued and outstanding at June 30, 2026 and December 31, 2025 10,371 6,841
Additional paid-in capital 53,949,594 31,215,698
Deferred compensation (26,834)
Accumulated deficit (49,193,573) (28,746,939)
Total stockholders’ equity 4,739,558 2,475,600
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 12,443,908 $ 10,931,065